NEW YORK (GenomeWeb) – Is it possible to craft a framework for regulating diagnostics that pleases everyone? A small group of labs and test manufacturers has taken a shot at it by coming up with its own proposal for regulating so-called in vitro clinical tests that it hopes will be an acceptable compromise for industry players that often disagree on the regulation of laboratory-developed tests (LDTs).

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.